Maypro introduces EubioQuercetin to North American market

Photo©iStockphoto.com/Bluberries

Maypro (Purchase, NY) is introducing EubioQuercetin to the North American market as part of a new distribution partnership with Japan-based Alps Pharmaceutical. According to the press release, EubioQuercetin is highly absorbable and 6500x more water-soluble than conventional, commercially available quercetin.

“Manufacturers that include EubioQuercetin in their formulations can formulate with a low daily dose of 125 mg for natural anti-aging efficacy compared to conventional quercetin, which requires manufacturers to include quercetin at doses as high as 1,000 mg,” said Isabel Elias-Castro, president of the Maypro Global Nutrition Group, in a press release.

According to Alps Pharmaceutical, EubioQuercetin was developed using a proprietary technology that optimizes 100% of the natural quercetin found in plants, including a unique non-digestible oligosaccharide prebiotic, rutinose.

“We’re happy to partner with Maypro on the North American introduction of our EubioQuercetin ingredient, which we refer to as ‘The World’s First Evolved Prebiotic Quercetin,’” said Osamu Ushimaru, president of Alps Pharmaceuticals. “Without artificial modification, we devised a method to increase the solubility and absorption in the body while maintaining the delivery of Quercetin-Rutinoside to the colon, thereby achieving the combined effects of rutinose and quercetin.”

A potent antioxidant, the company also says that EubioQuercetin, in aqueous solution, has an ORAC score 1,300x greater than conventional quercetin.